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ABSTRACT
Introduction: A correlational type investigation was carried out evaluating 145 patients with COVID-19
sepsis. Objectives: To determine whether hypoalbuminemia is a predictor of mortality and to identify
the serum albumin value most frequently related to lethality. Method: Patients older than or equal to 18
years seen at Hospital II Chocope during May to August 2020 were included. Patients with oncological
pathologies and incomplete medical records were excluded. The documentary analysis technique was
used, by reviewing medical records. Results: There was a statistically significant association between
hypoalbuminemia and mortality (p=0.014), patients with hypoalbuminemia had 3 times the risk of dying.
(OR=3.97 95% CI of 1,24-12,74). Likewise, the highest sensitivity and specificity of the test was when the
cut-off point for hypoalbuminemia was 1.38 g / dl. Finally, the most frequent comorbidity was arterial
hypertension. Conclusions: Hypoalbuminemia can be a predictor of mortality in patients with sepsis due
to COVID-19 at the Hospital de Chocope because it has a statistically significant association, with three
times the risk of death. The highest sensitivity and specificity was obtained with an albuminemia cutoff of
1.38 g / dL. The most frequent comorbidity in patients with sepsis due to COVID-19 who died was arterial
hypertension.
Key words: Hypoalbuminemia; Mortality; Sepsis; COVID-19 (source: MeSH NLM).

RESUMEN
Introducción: Se realizó una investigación de tipo correlacional evaluando a 145 pacientes con sepsis
por COVID-19. Objetivos: Determinar si la hipoalbuminemia es predictor de mortalidad de sepsis por
COVID-19 e identificar el valor sérico de albumina más frecuentemente relacionado con la letalidad.
Métodos: Se incluyeron a pacientes mayores o igual de 18 años atendidos en el Hospital II Chocope
durante mayo a agosto del 2020. Se excluyeron a pacientes con patologías oncológicas, e historias clínicas
incompletas. La técnica empleada es la de análisis documental, mediante la revisión de historias clínicas.
Resultados: Hubo asociación estadísticamente significativa entre la hipoalbuminemia y mortalidad
(p=0,014), los pacientes con hipoalbuminemia tuvieron 3 veces más riesgo de fallecer. (OR=3,97 IC al 95%
de 1,24-12,74). Así mismo, la sensibilidad y especificidad más alta de la prueba fue cuando el punto de
corte de la hipoalbuminemia estuvo en 1,38 g/dL. Finalmente, la hipertensión arterial es la enfermedad
asociada más frecuente. Conclusiones: La hipoalbuminemia puede ser un predictor de mortalidad en
pacientes con sepsis por COVID-19 en el Hospital de Chocope por tener asociación estadísticamente
significativa, con tres veces más riesgo de fallecer. La sensibilidad y especificidad más alta se obtuvo con
un punto de corte de albuminemia de 1,38 g/dL. La comorbilidad más frecuente en pacientes con sepsis
por COVID-19 que fallecieron fue la hipertensión arterial.
Palabras clave: Hipoalbuminemia; Mortalidad; Sepsis; COVID-19 (fuente: DeCS BIREME).
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INTRODUCTION

Chocope medical service from May to August 2020.

Sepsis is the main cause of death in hospitalized
critically ill patients with a high mortality rate(1,2). Each
year in the United States, 751,000 cases of sepsis are
reported with an approximate mortality of 26.6%
and an annual cost of 16.7 billion dollars, increasing
by 9% each year(3). Likewise, the incidence of sepsis
is also high in our country(4). Despite advances in
diagnostic methods and therapeutic management,
sepsis continues to be a challenge for different
doctors in our country.

Population and sample

Likewise, currently, cases of sepsis have increased
with COVID-19 as the main causal agent. This
being a highly contagious virus. Since the first case
was discovered in December 2019 in Wuhan, the
COVID-19 infection has spread rapidly. Until March
5, 2020, around 86 countries, including six in Latin
America, had reported at least one laboratoryconfirmed case of COVID-19, which is why the
COVID-19 outbreak was declared a pandemic,
reaching our territory on March 6, 2020(5).

Patients aged 18 years or older with a diagnosis
of COVID-19 sepsis were included based on the
diagnosis given in the clinical record. Also, the
following were considered as exclusion criteria:
pathologies also associated with hypoalbuminemia
and incomplete medical records (63 stories).

In Peru, the case curve is increasing. The group
of older adults have the highest mortality rate;
considering that the departments with the
highest deaths from COVID-19 are Ancash, Callao,
Ica, La Libertad, Lambayeque, Lima, and Piura(7).
Hypoalbuminemia being a frequent condition in
older adults, it is considered important to establish
whether hypoalbuminemia is a predictor of
mortality. Therefore, the objective of the study was to
determine whether hypoalbuminemia is a predictor
of mortality in patients with sepsis due to COVID-19
hospitalized in the clinical service of Hospital II
Chocope in 2020 and to identify the serum albumin
value most frequently related to lethality.

METHODS
Design and study area
A retrospective survey was conducted in patients
diagnosed with COVID-19 sepsis in the Hospital II
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The unit of analysis was each of the patients with
covid-19 sepsis mentioned in the population using
their medical records.

Variables and instruments
The documentary analysis technique was used, by
reviewing the medical records that contained the
complete information required for the study. As well,
the instrument used was validated by the criteria of
3 judges, made up of 3 internal medicine specialists,
who gave their approval to the instrument.
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Currently, there are countries that are known to have
had a high mortality rate. For example, in March,
Spain presented a high rate of infected with 1,549
cases/million inhabitants, adding around 72,248
cases, continuing with Italy where 1,529 cases /
million inhabitants are reported with a total sum
of 92 472 cases and France with 493 cases / million
inhabitants, with a total of 39,964 cases(6).

208 patients diagnosed with COVID–19 sepsis
hospitalized in the medical service of Hospital II
Chocope from May to August 2020 were considered.
We worked with the total population for which the
sample will have a census character.

Hypoalbuminemia was measured as follows: mild
was considered to be between 3.5 g/dL to 3 g/dL,
moderate between 3 to 2.5 g/dL and severe when
less than 2.5 g/dL.

Procedures
Permission was obtained from the II Chocope
hospital director to access the file and proceed
with the collection of data from patients diagnosed
with sepsis by covid-19 during May to August 2020.
This information was filled in a collection form for
subsequent analysis in Excel.

Statistical analysis
The data were subjected to descriptive statistical
analysis using percentages, averages and the
interpretation of tables and graphs. Statistical
significant relationship and odds ratio were
determined to assess the risk of death. Likewise,
the SPSS version 25 statistical software was used to
perform the ROC curve to find the best cutoff point
for predicting mortality.

Ethical aspects
Regarding ethical aspects, it had the permission of
Pág. 13
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Hospital II de Chocope, it also complies with article
42 of the Code of Ethics of the Medical College of
Peru and also complies with principle number 6 of
the Declaration of Helsinki, in the 64th assembly
held in Strength(8).

López A et al

Since it is a retrospective study using medical records,
it was not necessary to request informed consent. It
ensures the confidentiality of the data provided(9).

RESULTS

Table 1. Hypoalbuminemia and mortality in patients with sepsis due to COVID - 19 hospitalized in the
medical service of hospital II Chocope.
Mortality
Total
Yes

ORIGINAL PAPER

Hypoalbuminemia

No

n

%

n

%

n

%

Yes

67

94.4%

59

80.8%

126

87.5%

No

4

5.6%

14

19.2%

18

12.5%

Total

71

100.0%

73

100.0%

144

100.0%

Odds ratio = 3.97 I.C. al 95% [ 1.24; 12.74 ] X2 = 6.04 p = 0.014 *

In this table we observe that 94.4% of the patients
who died presented hypoalbuminemia; while in the
group of patients who did not die, hypoalbuminemia
appeared in 80.8%. It was determined that there
is a statistically significant association between
hypoalbuminemia and patient mortality (p = 0.014).
Also, a 3.97 times greater risk of death was identified
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when presenting hypoalbuminemia in relation to the
group of patients who presented normal albumin
(OR = 3.97 95% CI 1.24 to 12.74). On the other hand,
the mean albumin values for the patients who died
were 2.38 g / dl (± 0.67) vs. at 3.02 g / dl (± 0.65) for
the other group.

3

Revista de la Facultad de Medicina Humana, Vol.
21 [2021], Iss. 1, Art. 3
Hypoalbuminemia as a predictor of sepsis mortality from COVID-19

Rev. Fac. Med. Hum. 2021;21(1):12-18.

Table 2. Serum albumin levels and lethality in patients with sepsis due to COVID - 19 hospitalized in the
Medical service Hospital II Chocope, 2020.
Mortality
Total
Yes

Serum albumin level

No

%

n

%

n

%

Normal

4

2.8%

14

9.7%

18

12.5%

Mild

5

3.5%

38

26.4%

43

29.9%

Moderate

26

18.1%

10

6.9%

36

25.0%

Severe

36

25.0%

11

7.6%

47

32.6%

Total

71

49.3%

73

50.7%

144

100.0%
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n

X2 = 51.27 g.l. = 3 p = 0.000**

This table shows the highly significant relationship
between serum albumin levels and mortality (p
<0.001) in patients with covid-19 sepsis. Also, 25
% of the patients had a severe hypoalbuminemia
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level and died while 26.4% of patients had mild
hypoalbuminemia, and no deaths were recorded in
this group.
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Graphic1. ROC curve of hypoalbuminemia in relation to mortality in patients with sepsis due to COVID-19
hospitalized in the Medical service Hospital II Chocope 2020.
In graph 1, the area under the curve indicates that
the cut-off point for hypoalbuminemia, which

determines the highest sensitivity and specificity of
the test is 1.38 g/dL.

Graphic 2. Comorbidity in patients with sepsis due to COVID - 19 hospitalized in the Medical service
Hospital II Chocope, 2020

In this graph, it can be seen that the most frequent
comorbidity in patients with COVID - 19 sepsis was
arterial hypertension, represented by 33.3%, and in
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second place, both overweight and obesity (29.2%).
Likewise, 30.6% of patients did not present any
comorbidity.
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DISCUSSION
Although our finding of hypoalbuminemia as a
predictor of mortality is not new, and numerous studies
reported that hypoalbuminemia was associated with
increased mortality in different patient groups and
settings. It considers itself a poor prognostic factor
in inflammatory processes(8-14). This is one of the first
studies that evaluate hypoalbuminemia in patients
with sepsis due to COVID-19. Due to the current
contingency, it was necessary to have enough tools
to predict and prevent mortality.

Hypoalbuminemia in severe patients is related to
an increased pro-inflammatory response to various
infections. Both the severity of the disease and
hypoalbuminemia are closely related in adult and
pediatric patients(10,14).
Our results indicate an association between low
levels of albumin and increased mortality; the lower
the albumin level, the more frequent mortality was
evident in all age groups. This relates to the results
obtained by Luna J , et al.(16), whose albumin values
less than 3.5 g / dl within the first 2 days of admission
showed a high risk of death with an OR 1.5 higher,
especially in patients with albumin levels between
2.4-1.6 g / dl.
Cerpa et al.(17) analyzed 35 patients, with the mean
serum albumin of 2.84 g / dl in the group of patients
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Villalba S, et al.(18) found that among the factors
associated with high mortality is arterial hypertension
(p = 0.025), the same one that represents the 33.3%
of associated comorbidities in our study. Likewise,
Jellinge et al.(20) found that hypoalbuminemia’s
discriminatory capacity was good (AUROC 0.73 (95%
CI, 0.70-0.77)) and the calibration was acceptable,
similar to what our study obtained.
Our study focused on analyzing the albumin values
generally obtained in the first 24 hours of sepsis
patients due to COVID-19 admitted to the Medical
service. The results indicate high mortality in patients
with decreased albumin values and the population
at risk were adults with a predominance of older
adults and men. For this reason, we believe that
serum albumin control is important in all patients
who need hospitalization for COVID-19.

ORIGINAL PAPER

Albumin levels can decrease due to several factors:
poor nutritional status, inflammation (eg, infectious
disease, malignancy), due to interleukin-1 and tumor
necrosis factor that decrease albumin production
by the liver. Kidney disease or burns, due to loss of
albumin in the urine or integument, respectively.
Trauma or surgery results from associated stress,
which increases protein and energy requirements
by creating a hypermetabolic, catabolic state. And
also liver disease(15). Hypoalbuminemia patients may
manage critical illness somewhat differently than
patients with normal or high albumin levels.

with mortality and obtained a Chi 2 = 8.67 with a
significance level of p-value = 0.05, in addition all
the deceased patients presented hypoalbuminemia
almost similar to our study (94.4%).

Since the study was based on a review of medical
records, some data such as nutritional status and
body mass index did not register.
Another limitation was the lack of data on the specific
cause of mortality, and no information was available
on the intravenous administration of albumin during
hospitalization.

CONCLUSION
Hypoalbuminemia is a predictor of mortality in
patients with covid sepsis at the Hospital de Chocope
because it is highly significant, with 3 times higher risk
of dying. The highest sensitivity and specificity of the
test was when the cut-off point for hypoalbuminemia
was at 1.38 g / dl. The most frequent comorbidity in
patients with COVID-19 sepsis who died was arterial
hypertension.
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